Evidence map›Paper›PMID 26575107›Full record

ArticleVirulence2015

Characterization of unstable pEntYN10 from enterotoxigenic Escherichia coli (ETEC) O169:H41.

Erika Ban, Yuka Yoshida, Mitsuko Wakushima, Takeaki Wajima, Takashi Hamabata, Naoki Ichikawa, Hiroyuki Abe, Yasuhiko Horiguchi, Yukiko Hara-Kudo, Eriko Kage-Nakadai and 3 more

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Population characteristics of pathogenicFrontiers in microbiology · 2024
    Article
  4. Article
  5. Article
  6. Multidrug-Resistant Lineage of EnterotoxigenicFrontiers in microbiology · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Erika Bana Department of Food and Human Health Sciences ; Graduate School of Human Life Science; Osaka City University ; Osaka , Japan.
Yuka Yoshidaa Department of Food and Human Health Sciences ; Graduate School of Human Life Science; Osaka City University ; Osaka , Japan.
Mitsuko Wakushimaa Department of Food and Human Health Sciences ; Graduate School of Human Life Science; Osaka City University ; Osaka , Japan.
Takeaki Wajimab Department of Microbiology ; School of Pharmacy; Tokyo University of Pharmacy and Life Sciences ; Tokyo , Japan.
Takashi Hamabatac Research Institute; National Center for Global Health and Medicine ; Tokyo , Japan.
Naoki Ichikawaa Department of Food and Human Health Sciences ; Graduate School of Human Life Science; Osaka City University ; Osaka , Japan.
Hiroyuki Abed Department of Molecular Bacteriology ; Research Institute for Microbial Diseases; Osaka University ; Osaka , Japan.
Yasuhiko Horiguchid Department of Molecular Bacteriology ; Research Institute for Microbial Diseases; Osaka University ; Osaka , Japan.
Yukiko Hara-Kudoe Division of Microbiology; National Institute of Health Sciences ; Tokyo , Japan.
Eriko Kage-Nakadaif The OCU Advanced Research Institute for Natural Science and Technology; Osaka City University ; Osaka , Japan.
Taro Yamamotog Department of International Health ; Institute of Tropical Medicine; Nagasaki University ; Nagasaki , Japan.
Takayuki Wadag Department of International Health ; Institute of Tropical Medicine; Nagasaki University ; Nagasaki , Japan.
Yoshikazu Nishikawaa Department of Food and Human Health Sciences ; Graduate School of Human Life Science; Osaka City University ; Osaka , Japan.
Osaka City University · JPNagasaki University · JPOsaka University · JPNational Center for Global Health and Medicine · JPNational Institute of Health Sciences · JPTokyo University of Pharmacy and Life Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) serotype O169:H41 has been an extremely destructive epidemic ETEC type worldwide. The strain harbors a large unstable plasmid that is regarded as responsible for its virulence, although its etiology has remained unknown. To examine its genetic background specifically on the unstable retention and responsibility in the unique adherence to epithelial cells and enterotoxin production, the complete sequence of a plasmid, pEntYN10, purified from the serotype strain was determined. The length is 145,082 bp; its GC content is 46.15%. It contains 182 CDSs, which include 3 colonization factors (CFs), an enterotoxin, and large number of insertion sequences. The repertory of plasmid stability genes was extraordinarily scant. Uniquely, results showed that 3 CFs, CS6, CS8 (CFA/III)-like, and K88 (F4)-like were encoded redundantly in the plasmid with unique variations among previously known subtypes. These three CFs preserved their respective gene structures similarly to those of other ETEC strains reported previously with unique sequence variations respectively. It is particularly interesting that the K88-like gene cluster of pEntYN10 had 2 paralogous copies of faeG, which encodes the major component of fimbrial structure. It remains to be verified how the unique variations found in the CFs respectively affect the affinity to infected cells, host range, and virulence of the ETEC strain.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCattleDNA Transposable ElementsEnterotoxigenic Escherichia coliEnterotoxinsEpithelial CellsEscherichia coli InfectionsEscherichia coli ProteinsFimbriae, BacterialFimbriae ProteinsHumansMolecular Sequence DataMultigene FamilyPhylogenyDNA Transposable ElementsEnterotoxinsEscherichia coli ProteinsFimbriae Proteinscell adhesionEscherichia coliETECgenetic diversityplasmid

Identifiers

PMID26575107
PMCPMC4826094
OpenAlexW2181140670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.